Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. (MLYS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MLYS · as of Jun 8, 2026
Key Statistics
Explore Mineralys Therapeutics, Inc. Data
mlys stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
The MLYS analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $46.00, representing +98.49% upside from the current price of $23.18.
Competitors & Peers
mlys competitorsMLYS
ADPT
AGIO
APLS
BEAM
CDTXStock Performance
Full HistoryAbout Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product can…
what is mineralys therapeutics, inc. · mlys stock overview · mineralys therapeutics, inc. company profile · who is mineralys therapeutics, inc. ceo · mlys NASDAQ · mineralys therapeutics, inc. headquarters · mineralys therapeutics, inc. business segments
About Stock Overview & Key Data
Mineralys Therapeutics, Inc. (MLYS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 10, 2023. As of the latest trading session, MLYS stock price is $23.18, with a market capitalization of $1.5B. The stock has returned +40.89% over the past 12 months and -37.15% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Mineralys Therapeutics, Inc. stock is Buy, with an average 12-month price target of $46.00. In fiscal year 2025, Mineralys Therapeutics, Inc. reported revenue of — and net income of -$154.7M. For detailed data — including Mineralys Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mineralys Therapeutics, Inc. (MLYS) stock price is $23.18. The stock is traded on NASDAQ under the ticker symbol MLYS. The 52-week range is $12.59 – $47.65.